scispace - formally typeset
J

Janice E. Graham

Researcher at Dalhousie University

Publications -  107
Citations -  3802

Janice E. Graham is an academic researcher from Dalhousie University. The author has contributed to research in topics: Dementia & Public health. The author has an hindex of 24, co-authored 91 publications receiving 3354 citations. Previous affiliations of Janice E. Graham include Université de Montréal & University of Ottawa.

Papers
More filters
Journal ArticleDOI

Prevalence and severity of cognitive impairment with and without dementia in an elderly population

TL;DR: A comprehensive estimate of the prevalence of "cognitive impairment, no dementia" (CIND) in an elderly population of elderly Canadians and this diagnostic category includes a costly group of disorders that merit further study.
Journal ArticleDOI

Frailty, fitness and late-life mortality in relation to chronological and biological age.

TL;DR: The frailty index is a sensitive predictor of survival, compatible with a view of frailty as the failure to integrate the complex responses required to maintain function.
Journal ArticleDOI

Five-year follow-up of cognitive impairment with no dementia.

TL;DR: People with CIND were more likely to have a negative outcome than persons with NCI during a 5-year interval, which suggests that the use of specific diagnostic criteria sets does not improve the identification of those who develop dementia compared with a broader, more inclusive approach.
Journal ArticleDOI

Assessment of factors associated with complete immunization coverage in children aged 12-23 months: a cross-sectional study in Nouna district, Burkina Faso.

TL;DR: Specific factors associated with immunization status in Nouna health district are identified in order to advance improved intervention strategies in this district and in those with similar environmental and social contexts.
Journal ArticleDOI

Actor-Network Theory: a tool to support ethical analysis of commercial genetic testing

TL;DR: Treating this test as an active participant in socio-technical networks clarifies the extent to which it interacts with, shapes and is shaped by people, other technologies, and institutions and enables more sophisticated and nuanced technology assessment, academic analysis, and public debate about the social, ethical and policy implications of the commercialization of new genetic technologies.